Prevention of cardiovascular disease based on lipid lowering treatment: a challenge for the Mexican health system
Related Experiment Video
Updated: Jun 11, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Francisco J Gómez-Pérez1, Rosalba Rojas, Salvador Villalpando
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico.
Objective:
To estimate the percentage of Mexican adults that may require lipid-lowering treatment according to National Cholesterol Education Program-III guidelines, using data from the National Health and Nutrition Survey 2006 (ENSANut 2006).
Material And Methods:
Information was obtained from 4 040 subjects aged 20 to 69 years, studied after a 9 to 12 hours fast.
Results:
A cardiovascular risk equivalent was found in 13.8% and >or=2 risk factors were present in 31.5% of the population. LDL-C concentrations were above the treatment goal in 70% of the high-risk group and in 38.6% of subjects with >or=2 risk factors. Nearly 12 million Mexicans should be taught how to change their lifestyles and close to 8 million individuals require drug therapy to decrease their cardiovascular risk.
Conclusions:
Thirty percent of Mexican adults require some form of lipid-lowering treatment (lifestyle modifications in 36.25%, drug therapy in 24.19%).
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hypertension IV: Drug Therapy and Lifestyle Modifications
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care